Terpenes in ethanol: haloperidol permeation and partition through human skin and stratum corneum changes.
Carvacrol, linalool and alpha-terpineol (5% w/v) in 50% ethanol were used to enhance the permeation of haloperidol (HP) through human skin in vitro and their enhancement mechanism was investigated with HP-stratum corneum (SC) binding studies, fourier transform infrared spectroscopy (FT-IR) and differential scanning calorimetry (DSC). Carvacrol followed by terpineol and linalool enhanced flux and permeability coefficient but only carvacrol provided the required plasma concentration and the permeated daily doses. All terpenes increased the activity coefficient of HP in the skin. Carvacrol increased the lag time, which could be due to slow redistribution within SC. The thermogram of hydrated SC showed two lipid endotherms T1 and T2 at 65 and 78 degrees C and protein endotherm T3 at 97 degrees C. All endotherms were absent after SC treated for 48 h with 12 ml of terpene solutions and a decrease in melting points (m.p.) of lipids with a shift of protein endotherm were observed after 12 h treatment with 7 ml of terpene solutions. Linalool and terpineol decreased the m.p. of T1 to 33 degrees C. Carvacrol increased the T1 peak area, which was attributed to lateral lipid bilayer swelling. The IR spectra showed decreases in peak areas and heights of CH2 stretchings but did not show shift of these peaks, increase in their peak widths and shift in amide bands. All the three terpenes disrupted the lipid bilayer and extracted the lipids. Moreover, carvacrol increased the partition of HP whilst linalool and terpineol fluidized the lipids at skin temperature. There could be other possible protein-terpene interactions.
Vaddi
H K
HK
Department of Pharmacy, Faculty of Science, 18, Science Drive 4, National University of Singapore, 117543, Singapore, Singapore.
Ho
P C
PC
Chan
Y W
YW
Chan
S Y
SY
D014150:Antipsychotic Agents / Q000493:pharmacokinetics; D002492:Central Nervous System Depressants / Q000493:pharmacokinetics; D004817:Epidermis / Q000187:drug effects / Q000378:metabolism*; D000431:Ethanol / Q000493:pharmacokinetics*; D005260:Female; D006220:Haloperidol / Q000493:pharmacokinetics*; D006801:Humans; D010539:Permeability / Q000187:drug effects; D012869:Skin Absorption / Q000187:drug effects / Q000502:physiology*; D013729:Terpenes / Q000493:pharmacokinetics*
D014150:Antipsychotic Agents; D002492:Central Nervous System Depressants; D013729:Terpenes; D000431:Ethanol; D006220:Haloperidol